TOENAIL FUNGUS TREATMENT

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: TOENAIL FUNGUS TREATMENT
Generic name: 25% UNDECYLENIC ACID
Manufacturer: 100 KARMA INC
Product type: HUMAN OTC DRUG
SPL set ID: 3bb000dc-5e6c-b43b-e063-6394a90a63a9
SPL ID: 55b676ed-e1d8-1700-e063-6394a90a6ec3
Version: 3
Effective date: 2026-07-03
Source export date: 2026-09-28
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/bb1af06e95bcf9567b07e56fcf3a03c0cac3c7c82ff89d4c970881174949e5b7/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:47:50

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		TOENAIL FUNGUS TREATMENT	openfda.brand_name
generic name		25% UNDECYLENIC ACID	openfda.generic_name
manufacturer name		100 KARMA INC	openfda.manufacturer_name
ndc	package	85569-005-01	openfda.package_ndc
ndc	product	85569-005	openfda.product_ndc
ndc11	package	85569000501	derived:openfda.package_ndc
rxcui		998329	openfda.rxcui
spl id		55b676ed-e1d8-1700-e063-6394a90a6ec3	id
spl set id		3bb000dc-5e6c-b43b-e063-6394a90a63a9	set_id
unii		K3D86KJ24N	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only Do not use on children under 2 years of age unless directed by a doctor on diaper rash avoid contact with eyes. Do not exceed the recommended daily dosage unless directed by a doctor. Stop and ask a doctor if ▪ irritation occurs. ▪ there is no improvement within 4 weeks. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of accidental ingestion, seek medical advice immediately or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.